# Berry Oncology

Source: https://onco.cc/companies/berry-oncology/  
OnCo record `berry-oncology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Beijing cancer genomics company that launched HIFI Pan-Cancer Screening, a whole-genome blood test for six cancers, in 2022.

## Summary

Berry Oncology Corporation, whose staff give a Beijing address in their papers, publishes cell-free DNA tests for single cancers (liver, pancreatic, oesophageal, nasopharyngeal) and announced HIFI Pan-Cancer Screening for six cancers on 23 June 2022, with company-reported accuracy figures.

## Fields

- Kind: Company
- Last checked: 2026-11-03
- Also known as: Berry Oncology Corporation
- HQ: Beijing
- Type: diagnostics

## Sources

- Multi-cancer research release (13 October 2021): https://kyodonewsprwire.jp/release/202110141615

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [HIFI Pan-Cancer Screening (Berry Oncology)](https://onco.cc/drugs/hifi-pan-cancer-screening/)

---
JSON: https://onco.cc/api/v1/entities/berry-oncology.json